Effects of cryopreservation on immune responses: X. Decrease in interleukin-12 production by frozen human peripheral blood mononuclear cells is mediated by the endogenously hypersecreted interleukin-10

Cryobiology

Volumn 33, Issue 5, 1996, Pages 581-588

  Venkataraman, M ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELLULAR IMMUNITY; CRYOPRESERVATION; HUMAN; IMMUNOLOGY; MONONUCLEAR CELL;

CELLS, CULTURED; CRYOPRESERVATION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES;

EID: 0030267832     PISSN: 00112240     EISSN: None     Source Type: Journal    
DOI: 10.1006/cryo.1996.0061     Document Type: Article

References (27)

1. Anderson, R. E., Tokuda, S., Williams, W. L., and Warner, N. L. Radiation induced augmentation of the response of A/J mice to Sa I tumor cells. Am. J. Pathol. 108, 24-38 (1982).
2. Bellone G., and Trinchieri, G. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J. Immunol. 153, 930-937 (1994).
3. Benowitz, S. Scientists view bone marrow xenotransplant with optimism, caution. Scientist 10, 3, (1996).
4. Clerici, M., Lucey, D. R., Berzofsky, J. A., Pinto, L. A., Wynn, T. A., Blatt, S. P., Dolan, M. J., Hendrix, C. W., Wolf, S. F., and Shearer, G. M. Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science 262, 1721-1724 (1993).
5. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E., Chizzonite, R., Wolf, S. F., and Trinchieri, G. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398 (1992).
6. D'Andrea, A., Aste, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. Interleukin-10 inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048 (1993).
7. Fallarino, F., Uyttenhove, C., Boon, T., and Gajewski, T. F. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J. Immunol. 156, 1095-1100 (1996).
8. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S., and Bloom, B. R. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155, 2515-2524 (1995).
9. Hellstrom, K. E., Hellstrom, I., Kant, J. A., and Tamerius, J. D. Regression and inhibition of sarcoma growth by interference with a radiosensitive T cell population. J. Exp. Med. 148, 799-804 (1978).
10. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845 (1989).
11. North, R. J. Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. J. Exp. Med. 164, 1652-1666 (1986).
12. Orange, J. S., and Biron, C. A. An absolute and restricted requirement of IL-12 in natural killer cell IFN-y production and antiviral defense. J. Immunol. 156, 1138-1142 (1996).
13. Rowley, S., Bensinger, W. I., Gooley, T. A., and Buckner, C. D. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 83, 2731-2736 (1994).
14. Seder, R. A., Grabstein, K. H., Berzofsky, J. A., and McDyer, J. F. Cytokine interactions in human immunodeficiency virus-infected individuals: Roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182, 1067-1077 (1995).
15. Snijders, A., Hilkens, C. M. U., van der Pouw, T. C. T. M., Engel, M., Aarden, L. A., and Kapsenberg, M. L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156, 1207-1212 (1996).
16. Stevenson, M. M., Tam, M. F., Wolf, S. F., and Sher, A. IL-12-induced protection against blood-stage Plasmodium chabaudi requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545-2556 (1995).
17. Tannenbaum, C. S., Wicker, N., Armstrong, D., Tubbs, R., Finke, J., Bukowski, R. M., and Hamilton, T. A. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol. 156, 693-699 (1996).
18. Trinchieri, G. Interleukin-12 and its role in the generation of Th 1 cells. Immunol. Today 14, 35-38 (1993).
19. Trinchieri, G., and Scott, P. The role of interleukin-12 in the immune response, disease, and therapy. Immunol. Today 15, 461-463 (1994).
20. Venkataraman, M. Effects of cryopreservation on immune responses: IX. Stimulus mediated dichotomy in IL-10 production by frozen human peripheral blood mononuclear cells. J. Hematother. 5, 301-308, 1996.
21. Venkataraman, M. Effects of cryopreservation on immune responses: VII. Freezing induced enhancement of IL-6 production in human peripheral blood mononuclear cells. Cryobiology 31, 468-477 (1994).
22. Venkataraman, M. Cryopreservation-induced enhancement of interleukin-2 production in human peripheral blood mononuclear cells. Cryobiology 29, 165-174 (1992).
23. Venkataraman, M., and Westerman, M. P. Radiation causes increased production and decreased utilization of IL-2 in human mononuclear cells. Cytokine 2, 35-44 (1990).
24. Venkataraman, M. Effects of cryopreservation on immune responses: VIII. Enhanced secretion of interferon-γ by frozen human peripheral blood mononuclear cells. Cryobiology 32, 528-534 (1995).
25. Venkataraman, M., and Westerman, M. P. Cryopreservation enhances interleukin-1 production in human peripheral blood mononuclear cells. Cryobiology 27, 137-142 (1990).
26. Williams, S. F., Bitran, J. D., Richards, J. M., DeChristopher, P. J., Barker, E., Conant, J., Golomb, H. M., and Orlina, A. R. Peripheral blood derived stem cell collections for use in autologous transplantations after high dose chemotherapy: An alternative approach. Bone Marrow Transplant. 5, 129-133 (1990).
27. Zitvogel, L., Tahara, H., Robbins, P. D., Storkus, W. J., Clarke, M. R., Nalesnik, M. A., and Lotze, M. T. Cancer immunotherapy of established tumors with IL-12: Effective delivery by genetically engineered fibroblasts. J. Immunol. 155, 1393-1403 (1995).